Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
IMCIVREE (setmelanotide) is a treatment that targets the impaired MC4R pathway in the brain, addressing a root cause of weight gain and hunger. It is indicated for acquired hypothalamic obesity, Bardet-Biedl syndrome, and deficiencies in POMC
Parse Score
Sources
wp.nyu.edu shapes more of what AI says about Imcivree than any other source, at 100% of its citations.